| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 199,407 | 2,255,996 | ||
| Accounts receivable | 309,085 | 189,597 | ||
| Prepaid expenses | 460,070 | 474,468 | ||
| Other current assets | 363,515 | 343,246 | ||
| Total current assets | 1,332,077 | 3,263,307 | ||
| Property and equipment, net | 4,243,486 | 4,500,065 | ||
| Operating lease right-of-use assets | 572,289 | 635,041 | ||
| Intangible assets, net | 301,033 | 306,377 | ||
| Total assets | 6,448,885 | 8,704,790 | ||
| Accounts payable | 3,114,430 | 2,351,261 | ||
| Accrued liabilities | 4,585,137 | 4,389,312 | ||
| Deferred revenue | 354,000 | 122,441 | ||
| Management and directors' fees payable | 115,822 | 54,392 | ||
| Current portion of long-term debt | 913,582 | 1,017,348 | ||
| Current portion of finance lease liabilities | 54,020 | 53,842 | ||
| Current portion of operating lease liabilities | 254,644 | 252,013 | ||
| Current portion of grant repayable | 69,123 | 69,345 | ||
| Warrant liability | 112,770 | 140,612 | ||
| Derivative liability | 319,347 | 623,790 | ||
| Current portion of convertible note payable, net | 1,529,152 | 166,522 | ||
| Total current liabilities | 11,422,027 | 9,240,878 | ||
| Deferred revenue, net of current portion | 22,026,769 | 22,663,400 | ||
| Long-term debt, net of current portion | 5,565,751 | 5,771,375 | ||
| Finance lease liabilities, net of current portion | 331,550 | 346,291 | ||
| Operating lease liabilities, net of current portion | 351,211 | 417,015 | ||
| Grant repayable, net of current portion | 442,494 | 443,911 | ||
| Convertible note payable, net of current portion | 2,258,645 | 2,920,242 | ||
| Total long-term liabilities | 30,976,420 | 32,562,234 | ||
| Total liabilities | 42,398,447 | 41,803,112 | ||
| Authorized 325,000,000 shares of common stock, at 0.001 par value per share issued and outstanding 109,620,405 shares and 96,097,485 shares, respectively | 109,620 | 103,982 | ||
| Additional paid-in capital | 212,307,711 | 209,777,146 | ||
| Accumulated other comprehensive income | -421,946 | -444,294 | ||
| Accumulated deficit | -246,630,538 | -241,252,180 | ||
| Total volitionrx limited stockholders' deficit | -34,635,153 | -31,815,346 | ||
| Non-controlling interest | -1,314,409 | -1,282,976 | ||
| Total stockholders' deficit | -35,949,562 | -33,098,322 | ||
| Total liabilities and stockholders' deficit | 6,448,885 | 8,704,790 | ||
VOLITIONRX LTD (VNRX)
VOLITIONRX LTD (VNRX)